Alarmin S100A8 imparts chemoresistance of esophageal cancer by reprogramming cancer-associated fibroblasts
-
Published:2024-06
Issue:6
Volume:5
Page:101576
-
ISSN:2666-3791
-
Container-title:Cell Reports Medicine
-
language:en
-
Short-container-title:Cell Reports Medicine
Author:
Chen Xinjie,
Cheng Guoyu,
Zhu Liang,
Liu Tianyuan,
Yang Xinyu,
Liu Rucheng,
Ou Zhengjie,
Zhang Shaosen,
Tan Wen,
Lin Dongxin,
Wu ChenORCID
Reference90 articles.
1. Epidemiology of Esophageal Squamous Cell Carcinoma;Abnet;Gastroenterology,2018
2. Worldwide trends in esophageal cancer survival, by sub-site, morphology, and sex: an analysis of 696,974 adults diagnosed in 60 countries during 2000-2014 (CONCORD-3);Matz;Cancer Commun. (London, England),2023
3. How we treat esophageal squamous cell carcinoma;Puhr;ESMO open,2023
4. Perioperative management of esophageal cancer;Okines;Nat. Rev. Clin. Oncol.,2010
5. Hallmarks of cancer: the next generation;Hanahan;Cell,2011